1 / 25

Immunizations JFK pediatric core curriculum

Immunizations JFK pediatric core curriculum. MGH Center for Global Health Pediatric Global Health Leadership Fellowship Credits: Brett Nelson, MD, MPH. Discussion outline. Success of immunizations Still significant room for improvement Immunization schedules Administration of vaccines

mitch
Download Presentation

Immunizations JFK pediatric core curriculum

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ImmunizationsJFK pediatric core curriculum MGH Center for Global Health Pediatric Global Health Leadership Fellowship Credits: Brett Nelson, MD, MPH

  2. Discussion outline • Success of immunizations • Still significant room for improvement • Immunization schedules • Administration of vaccines • Contraindications • Specific vaccines

  3. Immunizations save lives Globally, immunizations save the lives of approximately 3 million people each year

  4. Vaccines are safe • Immunization is among safest of modern medical interventions • Vaccines are easier and safer to administer than ever before • Being immunized is much safer than risking infection and disease

  5. Immunization can save money • Immunization is one of the most cost-effective health interventions • Investing in vaccines SAVES more money than it costs

  6. Immunization can protect the unprotected • When immunization coverage is high, it can prevent viruses and bacteria from circulating • The more children in a community that are fully immunized, the safer everyone is • Unfortunately, ….

  7. 34 million children arenot fully immunized

  8. 2.3 million still die each year

  9. Diseases reappear when coverage drops

  10. Immunization coverage in Liberia Significant success over the last decade http://www.who.int/vaccines/globalsummary/immunization/countryprofileresult.cfm

  11. Liberia immunization schedule (coming soon?) http://www.who.int/vaccines/globalsummary/immunization/ScheduleSelect.cfm

  12. WHO EPI schedule by age WHO Pocket Book of Hospital Care for Children. Page 297.

  13. Administering vaccines • Most doses for children are 0.5ml IM or SC • Sites of IM/SC administration: • <18months: anterolateral thigh • Toddlers: anterolateral thigh or deltoid • Older children: deltoid • Give IM: • DTP, Hib, Hep B • Give SC: • Measles, yellow fever

  14. Contraindications to immunizations • Important to immunize all children, including those sick and malnourished, unless there are contraindications • Common side effects to vaccines: • Pain, local swelling, fever, fussiness, drowsiness, vomiting, anorexia • General contraindications to any vaccine: • History of anaphylaxis to that vaccine or vaccine component • Current moderate or severe illness regardless of fever

  15. Specific contraindications • BCG and yellow fever • Do not give BCG or yellow fever vaccines to child with symptomatic HIV/AIDS • But do give BCG and yellow fever vaccines to a child with asymptomatic HIV infection • DPT • Do not give DPT-2 or -3 to child who had seizures or shock within 3 days of previous DPT dose (possible encephalopathy to pertussis component)* • Do not give DPT to child with poorly controlled seizures or active CNS disease* *(If available, can give DT vaccine with no pertussis component) • OPV • A child with diarrhea who is due for OPV should be given OPV • However, this dose should not be counted in schedule • Make note on child’s immunization record that it coincided with diarrhea, so that health worker will know this and give an extra dose

  16. BCG vaccine • TB currently accounts for more deaths than any other infectious disease • Almost 3 million people a year, including nearly 300 000 children • Over 50 million people infected with drug-resistant strains • BCG (Bacille Calmette-Guérin) is a live vaccine • Administered intradermally (produces small raised "bleb“) at birth • Most widely used of all EPI vaccines • In 1997, almost 90% of the world’s children were immunized with BCG • 50-80% effective against most serious forms of childhood TB: miliary TB and TB meningitis • Offers some protection against leprosy • Uncertain protection against adult forms of TB • WHO recommendations: • In countries with high incidence of TB, immunize infants and children <5 years with single dose of BCG • Where definable high-risk population, countries may limit BCG to infants (such is schedule in Liberia) • Booster doses not recommended

  17. Oral polio vaccine • 2 kinds of polio vaccine • Inactivated injectable polio vaccine (IPV) originally developed in 1955 by Dr Jonas Salk • Live attenuated oral polio vaccine (OPV) developed by Dr Albert Sabin in 1961 • Both highly effective against all 3 types of poliovirus • OPV is vaccine of choice for eradication of poliomyelitis • 5x less expensive • Easier to administer (PO vs IM) • Most importantly, induces immunity in gut, where poliovirus multiplies • IPV provides individual protection against polio paralysis but not capable of preventing spread of wild poliovirus since induces very low immunity in gut • WHO recommendations: • 4 doses of OPV before first birthday (birth, 6, 10, 14 weeks) • However, supplementary doses are given during National Immunization Days to achieve eradication

  18. DTP vaccine • Combination vaccine against diphtheria, tetanus, and pertussis (whooping cough) • Given IM in 3 doses, at least 4 weeks apart (6, 10, 14 weeks) • Variations: • DT (full diphtheria and tetanus toxoid, but no pertussis) • Td (tetanus toxoid and reduced diphtheria; for adults) • TT (tetanus toxoid alone; for women of childbearing age) • Some countries have substituted acellular pertussis vaccine (aP) for whole-cell pertussis component (wP) • Some manufacturers have added Hepatitis B and/or Hib vaccine to simplify administration and reduce costs

  19. Hepatitis B vaccine • >2 billion people alive today have been infected with hepatitis B virus • Of these, ~350 million remain chronically infected, can transmit the infection, and can develop liver cirrhosis or cancer • Every year, ~4 million acute clinical cases of hepatitis B and ~1 million deaths • Primary liver cancer caused by hepatitis B is now one of principal causes of cancer death in many parts of Africa, Asia, and Pacific Basin • Globally, child-to-child and mother-to-child transmission accounts for majority of infections and carriers • Also transmitted through sexual contact, unsterile needles or other medical equipment, infected blood products, skin piercing • Vaccine given IM in 3 doses, at least 4 weeks apart (6, 10, 14 weeks) • Same schedule as DTP • Although vaccine price has fallen, still more expensive than traditional EPI vaccines -- many developing countries cannot afford

  20. Hib vaccine • Haemophilus influenzae type b (Hib) causes serious bacterial infections • Meningitis, pneumonia, and infections of blood, bones, and joints (does not cause influenza) • ~3 million serious illnesses and 386,000 deaths each year • Most common between 4-18 months, but can occur in older children • Leaves 15-35% of survivors with permanent disabilities such as mental retardation or deafness • Vaccine available alone or combined with DTP or hepatitis B (e.g. DTwPHibHep) • WHO recommendations: • 3 doses given IM at 6, 10, and 14 weeks ("where resources permit its use and burden of disease is established“)

  21. Yellow fever vaccine • Yellow fever is untreatable, viral, hemorrhagic disease, transmitted by mosquitoes, with high fatality rate (30,000 deaths/year) • Yellow fever and measles vaccines are similar in nature and both administered SC at 9 months • WHO recommendations: • 1 dose SC at 9 months for all infants in ~45 countries comprising yellow fever belt of Africa and South America • Re-immunization not indicated as vaccine thought to produce virtually life-long immunity • (However, travelers to these countries require vaccine every 10 years)

  22. Measles vaccine • Among vaccine-preventable diseases, measles remains the leading cause of child deaths • Nearly 1 million deaths every year, mainly in developing countries • However, even eradication efforts in developed countries like the U.S. have not been successful • Live attenuated vaccine • WHO recommendations: • Like yellow fever, 1 dose given SC at 9 months • Where >15% of measles cases and deaths occur before 9 months of age, give extra dose of measles vaccine at 6 months, then routine dose at 9 months • Also give extra measles dose for infants at high risk: infants in refugee camps, admitted to hospitals, HIV-positive, and affected by disasters or measles outbreaks • Oral Vitamin A drops often given at same time as measles vaccine to prevent blindness and reduce measles mortality

  23. Conclusions and implications • Vaccines are among safest and most effective medical interventions • Ensure up-to-date immunization status • Check records with each patient encounter • Give missing vaccines to hospitalized patients prior to discharge • One last review:

  24. References • Children’s Vaccine Program, Global Alliance of Vaccines and Immunizations. www.childrensvaccine.org • Immunization Action Coalition. http://immunize.org/catg.d/p2020.pdf • WHO. By-country vaccine schedule. www.who.int/vaccines/globalsummary/immunization/ScheduleSelect.cfm • WHO. Expanded programme on immunization – overview. http://wbln0018.worldbank.org/HDNet/HDdocs.nsf/0/6b9066a4c84916ec8525676a004d6c5e?OpenDocument • WHO. Liberia reported immunization coverage. http://www.who.int/vaccines/globalsummary/immunization/countryprofileresult.cfm • WHO. Pocket Book of Hospital Care for Children. http://www.who.int/child_adolescent_health/documents/9241546700/en/index.html

More Related